Conceptualizing a Model

The appropriate development of a model begins with understanding the problem that is being represented. The aim of this article is to provide a series of consensus-based best practices regarding the process of model conceptualization. For the purpose of this series of papers, the authors consider the development of models whose purpose is to inform medical decisions and health-related resource allocation questions. They specifically divide the conceptualization process into two distinct components: the conceptualization of the problem, which converts knowledge of the health care process or decision into a representation of the problem, followed by the conceptualization of the model itself, which matches the attributes and characteristics of a particular modeling type to the needs of the problem being represented. Recommendations are made regarding the structure of the modeling team, agreement on the statement of the problem, the structure, perspective and target population of the model, and the interventions and outcomes represented. Best practices relating to the specific characteristics of model structure, and which characteristics of the problem might be most easily represented in a specific modeling method, are presented. Each section contains a number of recommendations that were iterated among the authors, as well as the wider modeling taskforce, jointly set up by the International Society for Pharmacoeconomics and Outcomes Research and the Society for Medical Decision Making.

[1]  R. Shavelson,et al.  Problems and Issues in the Use of Concept Maps in Science Assessment. , 1996 .

[2]  Harlan M. Krumholz,et al.  Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. , 1992, The New England journal of medicine.

[3]  P. A. Mileman Decision making in health care. Theory, psychology, and applications , 2001 .

[4]  Oguzhan Alagoz,et al.  A Clinically Based Discrete-Event Simulation of End-Stage Liver Disease and the Organ Allocation Process , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[5]  Stirling Bryan,et al.  Modelling in the economic evaluation of health care: selecting the appropriate approach , 2004, Journal of health services research & policy.

[6]  J. Best,et al.  STRATEGY FOR RUBELLA VACCINATION , 1983, The Lancet.

[7]  Oguzhan Alagoz,et al.  Estimating the Unknown Parameters of the Natural History of Metachronous Colorectal Cancer Using Discrete-Event Simulation , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  David M Eddy,et al.  Validation of the archimedes diabetes model. , 2003, Diabetes care.

[9]  R. Willke,et al.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  Eric J Feuer,et al.  Dynamic Microsimulation Models for Health Outcomes , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  Medical Advisory Secretariat Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. , 2010, Ontario health technology assessment series.

[12]  A. Mulley,et al.  Management of acute dysuria. A decision-analysis model of alternative strategies. , 1985, Annals of internal medicine.

[13]  James E. Stahl,et al.  Pharmacoeconomics 2008; 26 (2): 131-148 , 2012 .

[14]  Jonathan Karnon,et al.  Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern , 2022 .

[15]  J. Caro,et al.  Modeling Using Discrete Event Simulation , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[16]  M L Brandeau,et al.  HIV transmission and the cost-effectiveness of methadone maintenance. , 2000, American journal of public health.

[17]  Giovanni Parmigiani,et al.  The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions , 1997, Annals of Internal Medicine.

[18]  Peter J Neumann,et al.  Costing and Perspective in Published Cost-Effectiveness Analysis , 2009, Medical care.

[19]  M. Drummond,et al.  Conflict of interest in industrysponsored economic evaluations: Real or imagined? , 2001, Current oncology reports.

[20]  Alberto J. Cañas,et al.  Florida Institute for Human and Machine Cognition (IHMC) , 2011 .

[21]  W. Leslie,et al.  The dynamics of HIV spread: a computer simulation model. , 1990, Computers and biomedical research, an international journal.

[22]  M. Weinstein,et al.  QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[23]  Anke Richter,et al.  Health and Economic Impacts of an HIV Intervention in Out of Treatment Substance Abusers: Evidence from a Dynamic Model , 2005, Health care management science.

[24]  David Henry,et al.  Economic Analysis as an Aid to Subsidisation Decisions , 2012, PharmacoEconomics.

[25]  A S Detsky,et al.  Primer on Medical Decision Analysis: Part 1—Getting Started , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[26]  Dan Greenberg,et al.  Bias in published cost effectiveness studies: systematic review , 2006, BMJ : British Medical Journal.

[27]  Marvin Zelen,et al.  Clinical Guidelines Annals of Internal Medicine Effects of Mammography Screening Under Different Screening , 2022 .

[28]  Uwe Siebert,et al.  Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[29]  David M. Eddy,et al.  Archimedes: a new model for simulating health care systems--the mathematical formulation , 2002, J. Biomed. Informatics.

[30]  M Sculpher,et al.  Review of guidelines for good practice in decision-analytic modelling in health technology assessment. , 2004, Health technology assessment.

[31]  D. Owens,et al.  State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[32]  S. Blower,et al.  Amplification Dynamics: Predicting the Effect of HIV on Tuberculosis Outbreaks , 2001, Journal of acquired immune deficiency syndromes.

[33]  J. Caro,et al.  Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  Chien-Chang Lee,et al.  Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. , 2007 .

[35]  D K Owens,et al.  Use of Influence Diagrams to Structure Medical Decisions , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[36]  Mirjam Kretzschmar,et al.  Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5 , 2012, Value in Health.

[37]  Gilles Clermont,et al.  Equation-based models of dynamic biological systems. , 2008, Journal of critical care.

[38]  M C Weinstein,et al.  The cost-effectiveness of preventing AIDS-related opportunistic infections. , 1998, JAMA.

[39]  S. Golder,et al.  Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment , 2012, PharmacoEconomics.

[40]  Gilles Clermont,et al.  A MATHEMATICAL SIMULATION OF THE INFLAMMATORY RESPONSE TO ANTHRAX INFECTION , 2008, Shock.

[41]  Sue J Goldie,et al.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches. , 2008, PharmacoEconomics.

[42]  Douglas K Owens,et al.  Potential population health outcomes and expenditures of HIV vaccination strategies in the United States. , 2009, Vaccine.

[43]  Przemyslaw Perlikowski,et al.  Understanding Coin-Tossing , 2010 .

[44]  Martin O'Flaherty,et al.  Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[45]  Jonathan Karnon,et al.  Model Parameter Estimation and Uncertainty Analysis , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[46]  Benjamin P. Linas,et al.  Improving Outcomes in State AIDS Drug Assistance Programs , 2009, Journal of acquired immune deficiency syndromes.

[47]  J. Eisenberg,et al.  Clinical Economics: A Guide to the Economic Analysis of Clinical Practices , 1989 .

[48]  R. Rosenheck,et al.  Quantitative analysis of sponsorship bias in economic studies of antidepressants. , 2003, The British journal of psychiatry : the journal of mental science.

[49]  Daniel Kahneman,et al.  A different approach to health state valuation. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[50]  A. Miners,et al.  Exploration of the difference in results of economic submissions to the National Institute of Clinical Excellence by manufacturers and assessment groups , 2007, International Journal of Technology Assessment in Health Care.

[51]  Michael Drummond,et al.  Moving the QALY forward: rationale for change. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[52]  Mirjam Kretzschmar,et al.  Dynamic Transmission Modeling , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[53]  Ross D. Shachter,et al.  Representation and Analysis of Medical Decision Problems with Influence Diagrams , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[54]  L. Goldman,et al.  Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. , 1987, American journal of public health.

[55]  Amy H Auchincloss,et al.  A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health. , 2008, American journal of epidemiology.

[56]  G. Clermont,et al.  In silico design of clinical trials: A method coming of age , 2004, Critical care medicine.

[57]  Erik Buskens,et al.  A tutorial on discrete-event simulation for health policy design and decision making: optimizing pediatric ultrasound screening for hip dysplasia as an illustration. , 2009, Health policy.

[58]  Chris T Bauch,et al.  Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience. , 2010, Vaccine.

[59]  A S Detsky,et al.  Primer on Medical Decision Analysis: Part 2—Building a Tree , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.